These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11743060

  • 21. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M, Gungor D, Turan M, Ozisik G, Bingol N, Ozgurtas T, Ozdemir IC.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery.
    García-Fuentes E, García-Almeida JM, García-Arnés J, Rivas-Marín J, Gallego-Perales JL, González-Jiménez B, Cardona I, García-Serrano S, Garriga MJ, Gonzalo M, de Adana MS, Soriguer F.
    Obes Surg; 2006 Sep; 16(9):1179-88. PubMed ID: 16989702
    [Abstract] [Full Text] [Related]

  • 25. Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch.
    Roslin MS, Dudiy Y, Brownlee A, Weiskopf J, Shah P.
    Surg Endosc; 2014 Jan; 28(1):91-9. PubMed ID: 24018763
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass.
    Gómez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, Catalán V, Rodríguez A, Cienfuegos JA, Frühbeck G.
    Obes Surg; 2007 May; 17(5):585-91. PubMed ID: 17658015
    [Abstract] [Full Text] [Related]

  • 29. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
    Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA, Pereira SG.
    Obes Surg; 2001 Dec; 11(6):693-8. PubMed ID: 11775566
    [Abstract] [Full Text] [Related]

  • 30. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
    Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS.
    Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery.
    To VT, Hüttl TP, Lang R, Piotrowski K, Parhofer KG.
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):547-52. PubMed ID: 23070831
    [Abstract] [Full Text] [Related]

  • 33. Massive weight loss does not restore normal insulin secretory pulses in obese patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Guichard-Rode S, Charrie A, Penet D, Teboul F, Thivolet C.
    Diabetes Metab; 1997 Dec; 23(6):506-10. PubMed ID: 9496556
    [Abstract] [Full Text] [Related]

  • 34. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
    Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.
    Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
    [Abstract] [Full Text] [Related]

  • 35. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.
    Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.
    Int J Obes (Lond); 2005 Jul; 29(7):766-71. PubMed ID: 15917853
    [Abstract] [Full Text] [Related]

  • 36. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.
    Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC.
    Diabetes Technol Ther; 2012 Apr; 14(4):365-72. PubMed ID: 22176155
    [Abstract] [Full Text] [Related]

  • 37. Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure.
    Ruiz-Tovar J, Boix E, Galindo I, Zubiaga L, Diez M, Arroyo A, Calpena R.
    Obes Surg; 2014 May; 24(5):791-5. PubMed ID: 24347349
    [Abstract] [Full Text] [Related]

  • 38. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [Abstract] [Full Text] [Related]

  • 39. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery.
    Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J.
    World J Surg; 2011 Sep; 35(9):2022-30. PubMed ID: 21691870
    [Abstract] [Full Text] [Related]

  • 40. Impact of Roux-en-Y gastric bypass on metabolic syndrome and insulin resistance parameters.
    Cazzo E, Gestic MA, Utrini MP, Machado RR, Geloneze B, Pareja JC, Chaim EA.
    Diabetes Technol Ther; 2014 Apr; 16(4):262-5. PubMed ID: 24299427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.